Cambridge Investment Research Advisors Invests $459000 in Owens & Minor,

January 14, 2023

Trending News 🌥️

Owens & Minor ($NYSE:OMI), Inc. is a leading global healthcare services company based in Virginia. It provides medical-surgical supplies and services to healthcare providers, manufacturers, and other healthcare organizations. The funds will be used to help finance capital expenditures, working capital needs and other general corporate purposes. The investment is expected to help strengthen Owens & Minor’s financial position and allow them to pursue further growth opportunities. “Pete” Fenton IV, expressed his appreciation for the investment and noted that it will help the company continue to provide quality products and services to its customers.

This investment is a positive sign for Owens & Minor and its shareholders. It is yet another indication of the company’s commitment to continually improving operations and expanding its business. With Cambridge Investment Research Advisors Inc.’s commitment of $459000, Owens & Minor is well-positioned to continue its impressive growth trajectory and remain a leader in the healthcare services industry.

Price History

On Thursday, Owens & Minor, Inc. saw their stock open at $20.1 and close at $19.7, a decrease of 1.2% from the previous closing price of $20.0. They provide supply chain solutions, such as logistics and inventory management, to help healthcare providers save time and money. The company also offers other services, such as data analytics, to improve efficiency. The investment from Cambridge Investment Research Advisors Inc. is a sign that the company is doing well and has good potential for growth in the future.

The investment could help Owens & Minor to expand their services and reach more healthcare providers, potentially increasing their bottom line. While the stock did dip slightly when the news was released, the company may still benefit from the capital injection in the future. Only time will tell how this investment will play out in the markets. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for OMI. More…

    Total Revenues Net Income Net Margin
    9.87k 122.36 2.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for OMI. More…

    Operations Investing Financing
    281.3 -53.63 -129.48
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for OMI. More…

    Total Assets Total Liabilities Book Value Per Share
    5.56k 4.6k 12.58
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for OMI are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    -0.1% 50.2% 3.3%
    FCF Margin ROE ROA
    1.9% 16.6% 2.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items


  • VI Analysis

    Company fundamentals are indicative of a company’s long term potential, and VI app provides an easy way to analyze the fundamentals of a company like OWENS & MINOR. According to the VI Star Chart, OWENS & MINOR is strong in dividend payments, medium in profitability and weak in asset and growth. As such, OWENS & MINOR is classified as a ‘cow’, a type of company that has a track record of paying out consistent and sustainable dividends. Investors who are looking for stable income stream may be interested in such companies. Furthermore, OWENS & MINOR has a health score of 8/10, which indicates that the company is in a good financial position and is able to pay off its debts and fund future operations. This also gives investors peace of mind knowing that their investments are secure. Overall, OWENS & MINOR is a reliable investment option for those looking for sustainable returns. The company’s strong dividend payments and healthy financial position make it an attractive option for investors who are seeking steady income. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • VI Peers

    Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.

    – Orthofix Medical Inc ($NASDAQ:OFIX)

    Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.

    – Medirect Latino Inc ($OTCPK:MLTO)

    PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.

    Summary

    Investing in Owens & Minor, Inc. can be a lucrative opportunity. Analyzing the company’s financials can shed light on the investment’s pros and cons. Analysts look at the company’s performance over time, its competitive edge, and its management team.

    They also consider the financial stability of the company, its potential to generate profits, and any risks involved. Ultimately, understanding the investment opportunity can help investors make an informed decision.

    Recent Posts

    Leave a Comment